HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuning Xie Selected Research

Complement C7 (Complement 7)

1/2022Functional genetic variants in complement component 7 confer susceptibility to gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuning Xie Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 01/2020
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2021
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2022 - 01/2020
2Esophageal Neoplasms (Esophageal Cancer)
07/2021 - 01/2021
2Lung Neoplasms (Lung Cancer)
06/2021 - 10/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2019
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1COVID-19
11/2021
1Cholelithiasis
07/2021
1Necrosis
07/2021
1Gallstones (Gallstone)
07/2021
1medullary Thyroid cancer
06/2021
1Colonic Neoplasms (Colon Cancer)
06/2021
1Glioblastoma (Glioblastoma Multiforme)
06/2021
1Insulin Resistance
01/2021
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1Cockayne Syndrome (Syndrome, Cockayne)
10/2019
1Carcinogenesis
01/2019

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
07/2021 - 01/2021
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 01/2020
2AntioxidantsIBA
07/2021 - 01/2020
2Pharmaceutical PreparationsIBA
10/2019 - 01/2019
1ORALIT (ORS)IBA
01/2022
1Complement C7 (Complement 7)IBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1NitratesIBA
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2021
1OxidesIBA
11/2021
1LipidsIBA
07/2021
1EnzymesIBA
07/2021
1CholesterolIBA
07/2021
1Bile Acids and Salts (Bile Acids)IBA
07/2021
1TeaIBA
07/2021
1RNA (Ribonucleic Acid)IBA
07/2021
1PhlorhizinIBA
07/2021
1Therapeutic UsesIBA
07/2021
1anlotinibIBA
06/2021
1Amino AcidsFDA Link
06/2021
1Type II DNA Topoisomerases (Topoisomerase II)IBA
06/2021
1Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
06/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1ElementsIBA
01/2021
116S Ribosomal RNAIBA
01/2021
1Carrier Proteins (Binding Protein)IBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1Toll-Like Receptor 4IBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2020
1Neuroprotective AgentsIBA
01/2020
1trans-sodium crocetinate (crocetin)IBA
01/2020
13' Untranslated Regions (3' UTR)IBA
01/2020
1CyclodextrinsIBA
01/2020
1IgA receptor (protein B)IBA
10/2019
1PlatinumIBA
10/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019

Therapy/Procedure

1Oral Administration
01/2021
1Therapeutics
01/2019